[go: up one dir, main page]

TW201613569A - Composition consisting of kukoamine A and/or kukoamine B and method of using thereof - Google Patents

Composition consisting of kukoamine A and/or kukoamine B and method of using thereof

Info

Publication number
TW201613569A
TW201613569A TW104126571A TW104126571A TW201613569A TW 201613569 A TW201613569 A TW 201613569A TW 104126571 A TW104126571 A TW 104126571A TW 104126571 A TW104126571 A TW 104126571A TW 201613569 A TW201613569 A TW 201613569A
Authority
TW
Taiwan
Prior art keywords
kukoamine
composition consisting
composition
disclosed
symptoms
Prior art date
Application number
TW104126571A
Other languages
Chinese (zh)
Other versions
TWI732741B (en
Inventor
Qiang Han
Ting-Zhao Li
min-jie Li
Bo Li
Hao Cen
Min Gui
Qin Du
Yao Zhang
Xiao-Juan Shen
Original Assignee
Access Business Group Int Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Access Business Group Int Llc filed Critical Access Business Group Int Llc
Publication of TW201613569A publication Critical patent/TW201613569A/en
Application granted granted Critical
Publication of TWI732741B publication Critical patent/TWI732741B/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A composition consisting of kukoamine A and/or kukoamine B and a method of using thereof are disclosed. The disclosed provides a composition containing at least the kukoamine A or kukoamine B, a use of applying the composition to treat or prevent orthopedics diseases and symptoms, and a method for improving bone health.
TW104126571A 2014-08-15 2015-08-14 Composition containing digucorin A and/or digucorin and method of use thereof TWI732741B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201410403053.8A CN105456241A (en) 2014-08-15 2014-08-15 Composition comprising kukoamine A and / or kukoamine B and application method thereof
CN201410403053.8 2014-08-15

Publications (2)

Publication Number Publication Date
TW201613569A true TW201613569A (en) 2016-04-16
TWI732741B TWI732741B (en) 2021-07-11

Family

ID=55594709

Family Applications (1)

Application Number Title Priority Date Filing Date
TW104126571A TWI732741B (en) 2014-08-15 2015-08-14 Composition containing digucorin A and/or digucorin and method of use thereof

Country Status (2)

Country Link
CN (1) CN105456241A (en)
TW (1) TWI732741B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106727469B (en) * 2016-11-11 2019-11-19 浙江中医药大学 Application of Digustin B in Preparation of Drugs for Treating Type Ⅱ Diabetes Mellitus
CN110870897B (en) * 2018-08-30 2022-03-25 湖北香连药业有限责任公司 Preparation method of cortex lycii radicis formula particles
CN110283781B (en) * 2019-06-24 2023-07-04 广州中医药大学第一附属医院 BMSCs ossification induction composition, culture medium and induction method
CN110491455B (en) * 2019-07-22 2023-01-24 广州中医药大学(广州中医药研究院) Application of lycium barbarum extract in preparation of antitumor drugs

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103735728B (en) * 2013-10-28 2016-08-31 赵庆春 Root bark of Chinese wolf-berry alcohol extract, Kukoamine and the B prime purposes in preparation has the medicine of neuroprotection

Also Published As

Publication number Publication date
TWI732741B (en) 2021-07-11
CN105456241A (en) 2016-04-06

Similar Documents

Publication Publication Date Title
IL264049A (en) Compounds, compositions, and methods for the treatment of disease
GB2541571A (en) Pharmaceutical compositions
IL264156A (en) Compounds, compositions, and methods for the treatment of disease
EP3166487A4 (en) Bone reconstruction and orthopedic implants
MY192927A (en) Fused bicyclic compounds for the treatment of disease
PH12017500621A1 (en) Triazolopyrazinones as pde1 inhibitors
IL251215A0 (en) Cannabinoid composition and method for treating pain
MX2017008456A (en) Fused bicyclic compounds for the treatment of disease.
MX2020006237A (en) Compounds for treatment of diseases related to dux4 expression.
MX356755B (en) Fumigillol type compounds and methods of making and using same.
EP3185905A4 (en) Compositions and methods for enhancing healing and regeneration of bone and soft tissue
EP4289820A3 (en) Compounds for use in treating alzheimer's disease in apoe4+/+ patients
PH12018500315A1 (en) Fumagillol heterocyclic compounds and methods of making and using same
NZ721835A (en) An osseointegrable device
MX382092B (en) Heterocyclic compounds for the treatment of disease
TW201613569A (en) Composition consisting of kukoamine A and/or kukoamine B and method of using thereof
PH12016501495A1 (en) Hexahydrofuropyrroles as pde1 inhibitors
MX370897B (en) Fused bicyclic compounds for the treatment of disease
TW201613610A (en) Use of ginsenoside M1 for treating lupus nephritis
IL251736B (en) Methods and compositions for the treatment of radiation-related disorders
GB201702549D0 (en) Composition for improved bone fracture healing
EP3256151A4 (en) Methods and compositions for treating muscle disease and disorders
MX2017003020A (en) Dipeptidyl ketoamide compounds and their use for the treatment and/or prevention of fat accumulation.
EP3226883C0 (en) COMPOSITIONS FOR THE TREATMENT OF DEGENERATIVE RETINAL DISEASES
ZA201607027B (en) Method for treating or enhancing muscle tissue